Individual patient data meta-analysis of time-to-event outcomes: one-stage versus two-stage approaches for estimating the hazard ratio under a random effects model

Research Synthesis Methods

Volumn 2, Issue 3, 2011, Pages 150-162

  Bowden, Jack ^a,b   Tierney, Jayne F ^a   Simmonds, Mark ^c   Copas, Andrew J ^a   Higgins, Julian PT ^b  

^a MRC CLINICAL TRIALS UNIT   (United Kingdom)

^b MRC BIOSTATISTICS UNIT   (United Kingdom)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

IPD meta analysis; one stage model; random effects; REML

Indexed keywords

EID: 84867048680     PISSN: None     EISSN: 17592887     Source Type: Journal    
DOI: 10.1002/jrsm.45     Document Type: Article

References (38)

1. Berry G, Kitchin RM, Mock PA. 1991. A comparison of two simple hazard ratio estimators based on the logrank test. Statistics in Medicine 10: 749–755.
2. Bowden J, Tierney J, Copas A, Burdett S. 2011. Quantifying, displaying and accounting for heterogeneity in the meta-analysis of RCTs using standard and generalised Q statistics. BMC Medical Research Methodology 11: 41.
3. Clarke M, Stewart L, Pignon JP, Bijnens L. 1998. Individual patient data meta-analyses in cancer. British Journal of Cancer 77: 2036–2044.
4. Collett D. 2003. Modelling Survival Data in Medical Research (2nd edn). Chapman & Hall/CRC, Boca Raton.
5. Cox DR. 1972. Regression models and life tables (with discussion). JRSSB 34: 187–220.
6. DerSimonian R, Laird N. 1986. Meta-analysis in clinical trials. Controlled Clinical Trials 7: 177–188.
7. Donohue M, Xu R. 2010. Proportional Hazards Mixed Effects Models (PHMM). Available at: http://cran.r-project.org/web/packages/phmm/phmm.pdf [Accessed in October 2010]
8. Dwan K, Altman DG, Arnaiz JA, Bloom J, Chan A-W, et al. 2008. Systematic review of the empirical evidence of study publication bias and outcome reporting bias. PLoS One 3(8): e3081.
9. Fisher DJ, Copas AJ, Tierney JF, Parmar MK. 2011. A critical review of methods for the assessment of patient-level interactions in individual patient data (IPD) meta-analysis of randomised trials, and guidance for practitioners. Journal of Clinical Epidemiology 64: 949–967.
10. Greenland S, Salvan A. 1990. Bias in the one-step method for pooling study results. Statistics in Medicine 9: 247–252.
11. Higgins JPT, Thompson SG, Spiegelhalter DJ. 2009. A re-evaluation of random-effects meta-analysis. Journal of the Royal Statistical Society: Series A 172: 137–159.
12. Ioannidis JPA. 2005. Why most published research findings are false. PLoS Medicine 2: 696–700.
13. Kalbfleisch JD, Prentice RL. 2002. The Statistical Analysis of Failure Time Data. New York: Wiley, 2nd Edition.
14. Lambert PC, Sutton AJ, Abrams KR, Jones DR. 2002. A comparison of summary patient level covariates in meta-regression with individual patient data meta-analysis. Journal of Clinical Epidemiology 55: 86–94.
15. McCullagh P, Nelder JA. 1983. Generalized Linear Models. Chapman and Hall, London.
16. McGilchrist CA. 1993. REML estimation for survival models with frailty. Biometrics 49: 221–225.
17. Meta-analysis Group in Cancer. 1998. Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer. Journal of Clinical Oncology 16: 301–308.
18. Michiels S, Baujat B, Mahe C, Sargent DJ, Pignon JP. 2005. Random effects survival models gave a better understanding of heterogeneity in individual patient data meta-analysis. Journal of Clinical Epidemiology 58: 238–245.
19. Parmar MKB, Torri V, Stewart L. 1998. Extracting summary statistics to perform meta-analysis of the published literature for survival endpoints. Statistics in Medicine 17: 2815–2834.
20. PORT Meta-analysis Trialists Group. 1998. Postoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patient data from nine-randomised controlled trials. Lancet 352: 257–263.
21. PORT Meta-analysis Trialists Group. 2005. Postoperative radiotherapy for non-small cell lung cancer. Cochrane Database of Systematic Reviews (2). Art. No.: CD002142. DOI: 10.1002/14651858.CD002142.pub2
22. Riley RD, Lambert PC, Zaid GA. 2010. Meta-analysis of individual patient data: rationale, conduct and reporting. British Medical Journal 340: c221.
23. Robinson GK. 1991. That BLUP is a good thing: the estimation of random effects. Statistical Science 6: 15–32.
24. Sargent DJ. 1998. A general framework for random effects survival analysis in the Cox proportional hazards setting. Biometrics 54: 1486–1497.
25. Simmonds M. 2005. Statistical methodology of individual patient data meta-analysis. PhD thesis, University of Cambridge.
26. Simmonds MC, Higgins JPT, Stewart LA, Tierney JF, Clarke MJ, Thompson SG. 2005. Meta-analysis of individual patient data from randomized trials: a review of methods used in practice. Clinical Trials 2: 209–217.
27. Stern JM, Simes RJ. 1997. Publication bias: evidence of delayed publication in a cohort study of clinical research projects. British Medical Journal 315: 640–645.
28. Stewart LA, Clarke MJ. 1995. Practical methodology of meta-analyses (overviews) using updated individual patient data Statistics in Medicine 14: 2057–2079.
29. Stewart LA, Parmar MKB. 1996. Bias in the analysis and reporting of randomized controlled trials. International Journal of Technology Assessment in Health Care 12: 264–275.
30. Stewart LA, Tierney JF. 2002. To IPD or not to IPD? Evaluation & the Health Professions 25: 76–97.
31. The Prophylactic Cranial Irradiation Overview Collaborative Group. 1999. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. The New England Journal of Medicine 341: 476–484.
32. Thernau TM, Grambsch PM, Pankratz VS. 2003. Penalized survival models and frailty. Journal of Computational and Graphical Statistics 12: 156–175.
33. Tudur-Smith C, Williamson PR. 2007. A comparison of methods for fixed effect meta-analysis of individual patient data with time to event outcomes. Clinical Trials 4: 621–630.
34. Tudur-Smith C, Williamson PR, Marson AG. 2005. Investigating heterogeneity in individual patient data meta-analysis of time to event outcomes. Statistics in Medicine 24: 1307–1319.
35. Vaida F, Xu R. 2000. Proportional hazards models with random effects. Statistics in Medicine 19: 3309–3324.
36. Williamson PR, Tudur-Smith C, Hutton JL, Marson AG. 2002. Aggregate data meta-analysis with time-to-event outcomes. Statistics in Medicine 21: 3337–3351.
37. Yamaguchi T, Ohashi Y. 1999. Investigating centre effects in a multi-centre clinical trial of superficial bladder cancer. Statistics in Medicine 18: 1961–1971.
38. Yusef S, Peto R. 1985. Beta blockade during and after myocardial infarction: an overview of the randomised trials. Progress in Cardiovascular Diseases 27: 335–371.